[18F]MNI-444

N/A

Report date: 2025/11/28 15:16:06

Base Information

Drug Name[18F]MNI-444
Drug Alias Name[18F]MNI-444
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancersAdenosine A2a receptor binders
TargetsAdenosine A2a receptor
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInvicro Llc
China Registration ClassN/A

Develop Information

Active CompaniesInvicro LlcUcb
Inactive CompaniesN/A
Active IndicationsDiagnostic agents
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A